Skip to main content
. 2016 Feb 24;7(13):16372–16383. doi: 10.18632/oncotarget.7688

Table 3. AUC, sensitivity, specificity, PPV and NPV of IgA-gH/gL and EBV DNA in IgA-VCA-negative NPC patients in the training cohort.

Test AUC (95%) pa Sensitivity pb Specificity pb PPV pc NPV pc
% 95% CI % 95% CI % 95% CI % 95% CI
gH/gL 0.879 (0.820-0.937) 78.1 63.6-92.4 82.3 77.0-87.6 42.0 29.5-54.5 96.0 93.0-99.0
EBV DNA 0.750 (0.637-0.863) 53.1 35.8-70.4 94.9 91.8-98.0 63.0 44.8-81.2 92.6 89.0-96.2
gH/gL vs. EBV DNA 0.003 0.021 <0.001 NS NS

PPV, positive predictive value; NPV, negative predictive value; NS, not significant; gH/gL, enzyme-linked immunosorbent assay detection of IgA antibodies against EBV glycoprotein complex gH/gL; VCA, immunofluorescence assay for IgA antibodies against viral capsid antigen; EBV DNA, qPCR test for plasma circulating EBV DNA.

a

Z test.

b

McNemar's paired-sample test.

c

Chi-squared test